Subscribe to our newsletter to receive the latest product updates and special offers

Order by Signal Tickers
Filters
Overview Valuation Financial Ownership Performance Technical ETF ETF Perf Custom Charts Tickers Basic TA News Snapshot Maps Stats
#141 / 177 Total
LCUT - Lifetime Brands, Inc. - Stock Price Chart
TickerLCUT [NASD]
CompanyLifetime Brands, Inc.
CountryUSA
IndustryFurnishings, Fixtures & Appliances
Market Cap234.16MEPS (ttm)-0.28
P/E-EPS this Y43.59%
Forward P/E10.98EPS next Y29.46%
PEG-EPS past 5Y-35.03%
P/S0.34EPS next 5Y10.00%
P/B1.05EPS Q/Q29.41%
Dividend1.60%Sales Q/Q-2.20%
Insider Own48.34%Inst Own35.54%
Insider Trans0.00%Inst Trans-0.27%
Short Float0.75%EarningsMay 09/b
Analyst Recom1.00Target Price12.83
Avg Volume69.90K52W Range4.31 - 11.08
Lifetime Brands, Inc. provides kitchenware and tableware products. It operates through the following segments: U.S. and International. The U.S. segment includes the domestic operations of the Company's business that design, market and distribute its products to retailers, distributors and directly to consumers through retail websites. The International segment includes business operations conducted outside the United States. The company was founded in 1945 and is headquartered in Garden City, NY.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Kay Robert BruceChief Executive OfficerMay 17 '23Buy5.033,00015,09066,000May 18 06:55 PM
BW - Babcock & Wilcox Enterprises Inc - Stock Price Chart
TickerBW [NYSE, RUT]
CompanyBabcock & Wilcox Enterprises Inc
CountryUSA
IndustrySpecialty Industrial Machinery
Market Cap115.43MEPS (ttm)-2.43
P/E-EPS this Y102.62%
Forward P/E5.16EPS next Y809.09%
PEG-EPS past 5Y46.93%
P/S0.12EPS next 5Y6.99%
P/B-EPS Q/Q-25.67%
Dividend-Sales Q/Q-19.32%
Insider Own5.79%Inst Own81.40%
Insider Trans7.91%Inst Trans5.89%
Short Float5.71%EarningsMay 09/a
Analyst Recom1.50Target Price4.50
Avg Volume1.63M52W Range0.75 - 6.64
Babcock & Wilcox Enterprises, Inc. engages in the provision of fossil and renewable power generation and environmental equipment. It operates through the following segments: B&W Renewable, B&W Environmental, and B&W Thermal. The B&W Renewable segment supports a circular economy, diverting waste from landfills to use for power generation and replacing fossil fuels, while recovering metals and reducing emissions. The B&W Environmental segment focuses on systems for cooling, ash handling, particulate control, nitrogen oxides and sulfur dioxides removal, chemical looping for carbon control, and mercury control. The B&W Thermal segment offers steam generation equipment, aftermarket parts, construction, maintenance, and field services for plants in the power generation, oil and gas, and industrial sectors. The company was founded by George H. Babcock, Stephen Wilcox, Jr., and Joseph P. Manton in 1856 and is headquartered in Akron, OH.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Morgan Jimmy BChief Operating OfficerMay 02 '24Option Exercise1.0549,01051,460518,717May 03 04:33 PM
Moeller Philip DDirectorMar 21 '24Buy1.1020,00022,00085,774Mar 22 08:04 AM
Young Kenneth MChief Executive OfficerMar 20 '24Buy1.0329,22930,001241,745Mar 22 08:00 AM
Salamone Louis JrChief Financial OfficerMar 20 '24Buy1.024,0004,080636,711Mar 22 08:01 AM
Tato Joseph ADirectorMar 18 '24Buy0.976,0005,81167,303Mar 20 04:32 PM
FNKO - Funko Inc - Stock Price Chart
TickerFNKO [NASD, RUT]
CompanyFunko Inc
CountryUSA
IndustryLeisure
Market Cap369.66MEPS (ttm)-2.51
P/E-EPS this Y89.37%
Forward P/E22.02EPS next Y454.05%
PEG-EPS past 5Y-
P/S0.35EPS next 5Y19.40%
P/B1.73EPS Q/Q61.82%
Dividend-Sales Q/Q-14.36%
Insider Own39.07%Inst Own62.50%
Insider Trans-0.23%Inst Trans5.17%
Short Float17.21%EarningsMay 09/a
Analyst Recom2.50Target Price8.88
Avg Volume490.18K52W Range5.27 - 13.42
Funko, Inc. engages in designing, sourcing, and distributing licensed pop culture products. Its product lines include media and entertainment content, which refer to movies, TV shows, video games, music, and sports. It operates through the United States, Europe, and Other International geographic segments. The company was founded in 1998 and is headquartered in Everett, WA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Daw Tracy DCHIEF LEGAL OFFICERApr 30 '24Sale6.063,75522,76262,425May 01 07:24 PM
Oddie Andrew DavidCHIEF COMMERCIAL OFFICERApr 30 '24Sale5.973,73022,25564,060May 01 07:22 PM
Le Pendeven YvesActing CFOApr 30 '24Sale5.958852328,848May 01 07:20 PM
Le Pendeven YvesActing CFOApr 29 '24Option Exercise0.00317028,936May 01 07:20 PM
Oddie Andrew DavidCHIEF COMMERCIAL OFFICERApr 29 '24Option Exercise0.007,314067,790May 01 07:22 PM
VTNR - Vertex Energy Inc - Stock Price Chart
TickerVTNR [NASD, RUT]
CompanyVertex Energy Inc
CountryUSA
IndustryOil & Gas Refining & Marketing
Market Cap112.68MEPS (ttm)-1.76
P/E-EPS this Y60.66%
Forward P/E-EPS next Y43.07%
PEG-EPS past 5Y-45.16%
P/S0.04EPS next 5Y20.00%
P/B0.63EPS Q/Q-400.00%
Dividend-Sales Q/Q0.61%
Insider Own9.34%Inst Own43.75%
Insider Trans-1.16%Inst Trans7.51%
Short Float20.05%EarningsMay 09/b
Analyst Recom2.43Target Price2.59
Avg Volume2.48M52W Range0.95 - 7.28
Vertex Energy, Inc. engages in refining and marketing conventional and lower-carbon alternative transportation fuels. It operates through Refining and Marketing and Black Oil and Recovery segments. The Refining and Marketing segment manages the refining of crude oil and renewable feedstocks, and distributes finished products across the Southeastern U. S. through truck rack. The Black Oil and Recovery segment aggregates and manages the re-refinement of used motor oil and other petroleum by-products and sells the re-refined products to end customers. The company was founded by Benjamin P. Cowart in 2001 and is headquartered in Houston, TX.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Khoury OdehDirectorApr 10 '24Sale1.162,2502,61017,784Apr 11 06:00 PM
Stratton Christopher AllenDirectorNov 10 '23Sale3.93100,000392,60088,405Nov 13 07:55 PM
Carlson ChrisCFOJul 06 '23Option Exercise2.96100,000296,0001,026,076Jul 07 07:02 PM
Ruiz AlvaroChief Strategy OfficerMay 20 '23Option Exercise1.456,2509,06287,500May 23 04:35 PM
Ruiz AlvaroChief Strategy OfficerMay 19 '23Option Exercise1.9225,00048,00081,250May 23 04:35 PM
FLYX - flyExclusive Inc. - Stock Price Chart
TickerFLYX [AMEX]
CompanyflyExclusive Inc.
CountryUSA
IndustryAirlines
Market Cap92.87MEPS (ttm)0.12
P/E45.49EPS this Y15.00%
Forward P/E-EPS next Y35.29%
PEG-EPS past 5Y-
P/S-EPS next 5Y-
P/B1.96EPS Q/Q1670.83%
Dividend-Sales Q/Q-
Insider Own87.52%Inst Own8.37%
Insider Trans0.17%Inst Trans0.50%
Short Float1.88%EarningsMay 02/a
Analyst Recom1.00Target Price9.00
Avg Volume55.28K52W Range3.39 - 24.21
flyExclusive, Inc. is a FAA regulated operator of private jet experiences offering customers on-demand charter, Jet Club and fractional jet services to destinations across the globe. It manages all aspects of the customer experience, in-house maintenance, repair and overhaul services, including paint, interiors and avionics capabilities, The company was founded by Thomas J. Segrave, Jr. in 2015 and is headquartered in Kinston, NC.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Hymowitz GreggDirectorMar 04 '24Buy1000.0025,00025,000,00025,000Mar 06 06:51 PM
TELO - Telomir Pharmaceuticals Inc - Stock Price Chart
TickerTELO [NASD]
CompanyTelomir Pharmaceuticals Inc
CountryUSA
IndustryBiotechnology
Market Cap204.61MEPS (ttm)-0.44
P/E-EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y-
P/S-EPS next 5Y-
P/B59.51EPS Q/Q-1820.73%
Dividend-Sales Q/Q-
Insider Own42.48%Inst Own0.13%
Insider Trans1.11%Inst Trans-
Short Float0.18%Earnings-
Analyst Recom-Target Price-
Avg Volume60.55K52W Range4.76 - 20.72
May-07-24 03:02PM Telomir Pharmaceuticals sees breakthrough potential in Anti-Aging Treatment with Telomir 1 (News Direct)
Apr-16-24 08:30AM Telomir Pharmaceuticals Unveils Compelling Pre-clinical Data on Age-Reversal Drug Telomir-1 at National Press Club Event in Washington, D.C. (GlobeNewswire) -5.32%
Apr-02-24 08:30AM Telomir Pharmaceuticals' Anti-Aging Expert and NYT Bestselling Author Michael F. Roizen, MD, to Present Promising Pre-Clinical Data for Age-Reversal Drug Telomir-1 at the National Press Club in Washington, DC, on April 15, 2024 (GlobeNewswire)
Mar-29-24 04:44PM UPDATE Telomir Pharmaceuticals Announces Collaboration with Argenta to Study Osteoarthritis in Canines (GlobeNewswire)
Mar-26-24 08:30AM Telomir Pharmaceuticals Announces Collaboration with Argenta to Study Osteoarthritis in Canines (GlobeNewswire)
Mar-22-24 08:30AM Telomir Pharmaceuticals Releases New Pre-Clinical Data for Telomir-1 to Be Presented at the Global Longevity Federation Conference in Las Vegas on March 26th (GlobeNewswire)
Mar-14-24 08:30AM Telomir Pharmaceuticals Uses AI Testing Models to Show its Lead Product Candidate's Potential in DNA Age Reversal Science (GlobeNewswire) -9.83%
Mar-07-24 08:30AM Telomir Pharmaceuticals Presents Promising Pre-Clinical Data For Its Lead Development Product at Singapore Conference (GlobeNewswire)
Mar-05-24 08:30AM Michael F. Roizen, MD to Increase Activities with Telomir Pharmaceuticals as Special Advisor on Age Reversal (GlobeNewswire)
Feb-13-24 04:05PM Telomir Pharmaceuticals Announces Closing of Initial Public Offering (GlobeNewswire) +12.16%
Telomir Pharmaceuticals, Inc. is a pre-clinical-stage pharmaceutical company, which focuses on the development and commercialization of TELOMIR-1, a novel small molecule being developed to function as an oral in situ therapeutic treatment for human stem cells. The firm's initial focus on treatments to inhibit the production of pro-inflammatory cytokines, such as IL-17, by oral administration of TELOMIR-1 as a therapeutic treatment for stem cells in situ. TELOMIR-1 is under investigation to provide a potential therapeutic intervention against age-related inflammatory conditions such as hemochromatosis, as well as for post-chemotherapy recovery, by interrupting and preventing the IL-17 induced inflammatory pathways that create the systemic imbalance of cellular metals. The company was founded by Christopher C. Chapman Jr. on August 26, 2021 and is headquartered in Baltimore, MD.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Bay Shore Trust10% OwnerFeb 13 '24Buy7.00138,000966,0005,455,431Feb 15 04:11 PM
UG - United-Guardian, Inc. - Stock Price Chart
TickerUG [NASD]
CompanyUnited-Guardian, Inc.
CountryUSA
IndustryHousehold & Personal Products
Market Cap38.79MEPS (ttm)0.56
P/E15.04EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y-9.92%
P/S3.56EPS next 5Y-
P/B3.41EPS Q/Q8.59%
Dividend4.14%Sales Q/Q-5.64%
Insider Own36.39%Inst Own23.96%
Insider Trans0.00%Inst Trans-6.65%
Short Float0.05%Earnings-
Analyst Recom-Target Price-
Avg Volume7.25K52W Range5.79 - 10.23
United-Guardian, Inc. engages in the development and manufacture of pharmaceuticals, cosmetic ingredients, personal and health care products and medical devices. The firm also conducts research and product development related to the development of new and unique cosmetic and personal care products. The company was founded by Alfred R. Globus in 1942 and is headquartered in Hauppauge, NY.
CIA - Citizens, Inc. - Stock Price Chart
TickerCIA [NYSE]
CompanyCitizens, Inc.
CountryUSA
IndustryInsurance - Life
Market Cap122.59MEPS (ttm)0.48
P/E5.13EPS this Y-35.42%
Forward P/E5.81EPS next Y37.10%
PEG-EPS past 5Y-
P/S0.51EPS next 5Y-
P/B0.63EPS Q/Q-6.75%
Dividend-Sales Q/Q3.22%
Insider Own9.83%Inst Own14.38%
Insider Trans0.49%Inst Trans-6.39%
Short Float9.45%EarningsMay 08/b
Analyst Recom1.00Target Price3.75
Avg Volume63.31K52W Range1.64 - 3.69
Citizens, Inc. is a holding company, which engages in the provision of insurance and reinsurance services. It operates through the Life Insurance and Home Service Insurance segments. The Life Insurance segment primarily issues ordinary whole life insurance and endowment policies in U.S. dollar-denominated amounts to foreign residents. The Home Service Insurance segment focuses on the life insurance needs of the middle- and lower-income markets. The company was founded by Harold Eugene Riley in 1969 and is headquartered in Austin, TX.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
MANESS TERRY SAMDirectorApr 05 '24Buy2.141,0002,13715,947Apr 08 05:28 PM
MORGAN JAMES KEITHDirectorMar 26 '24Buy2.115,89912,46961,965Mar 27 03:01 PM
MORGAN JAMES KEITHDirectorMar 22 '24Buy1.981,1012,18056,066Mar 25 11:52 AM
Shields GeraldPresident & CEOMar 21 '24Buy2.2216,00035,520168,724Mar 22 03:45 PM
MORGAN JAMES KEITHDirectorAug 09 '23Buy2.923,1109,08154,965Aug 10 02:01 PM
GAN - GAN Limited - Stock Price Chart
TickerGAN [NASD]
CompanyGAN Limited
CountryUSA
IndustryGambling
Market Cap60.45MEPS (ttm)-0.90
P/E-EPS this Y45.72%
Forward P/E-EPS next Y40.03%
PEG-EPS past 5Y-23.98%
P/S0.48EPS next 5Y-
P/B-EPS Q/Q-389.94%
Dividend-Sales Q/Q-12.75%
Insider Own1.35%Inst Own17.16%
Insider Trans0.00%Inst Trans-10.02%
Short Float1.38%EarningsMay 09/a
Analyst Recom3.00Target Price1.97
Avg Volume195.13K52W Range0.83 - 2.07
GAN Ltd. engages in the development and sale of internet gambling software-as-a-service solutions. It operates through the Business-to-Business (B2B) and Business-to-Consumer (B2C) segments. The B2B segment develops, markets, and sells instances of iSight Back Office and GameSTACK that incorporates comprehensive player registration, account funding and back-office accounting and management tools that enable the casino operators to extend their presence online in places that have permitted online real money gaming. The B2C segment includes the operations of Coolbet and develops and operates a B2C online sports betting and casino platform that is accessible through its website in markets across Northern Europe, Latin America, and Canada. The company was founded in 2019 and is headquartered in Irvine, CA.
TCON - TRACON Pharmaceuticals Inc - Stock Price Chart
TickerTCON [NASD]
CompanyTRACON Pharmaceuticals Inc
CountryUSA
IndustryBiotechnology
Market Cap4.40MEPS (ttm)-5.20
P/E-EPS this Y-115.76%
Forward P/E-EPS next Y22.33%
PEG-EPS past 5Y61.51%
P/S0.37EPS next 5Y-
P/B-EPS Q/Q103.48%
Dividend-Sales Q/Q-
Insider Own7.89%Inst Own11.30%
Insider Trans0.00%Inst Trans-
Short Float7.29%EarningsMay 14/a
Analyst Recom1.67Target Price37.50
Avg Volume257.50K52W Range1.59 - 14.75
TRACON Pharmaceuticals, Inc. engages in the development and commercialization of targeted therapies for cancer, and ophthalmic and fibrotic diseases. Its products include TRC105, an anti-endoglin antibody for the treatment of solid tumor types, TRC205 created for the treatment of fibrotic diseases, and TRC102, a small molecule that is in clinical development made for lung cancer and glioblastoma. The company was founded in October 2004 and is headquartered in San Diego, CA.
1101112131415161718